A study of mRNA-1273 (Moderna) vaccine in patients with either kidney or kidney-pancreas grafts
Latest Information Update: 03 Aug 2022
At a glance
- Drugs Elasomeran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 08 Jun 2022 Results (n=105) evaluating the evolution of both humoral and cellular response before and 1 month after the administration of the third dose of mRNA-1273, presented at the 2022 American Transplant Congress.
- 07 Jun 2021 New trial record
- 26 May 2021 Results published in the American Journal of Transplantation